At its 41st meeting held in November 2018, the ECDD reviewed the chemistry, pharmacology, toxicology, therapeutic use, epidemiology and drug dependence of cannabis and related compounds including tetrahydrocannabinol (THC), a number of opioids and synthetic derivatives, as well as pregabalin and N‑ethylnorpentylone.

Expert Committee on Drug Dependence (2018). Forty-first meeting of the Expert Committee on Drug Dependence. 12-16 November 2018. Critical reviews available at: https://www.who.int/medicines/access/controlled-substances/ecdd_41_meeting/en/

 

The above items were taken from the January/February 2019 issue of Toxicology and Regulatory News which is sent automatically to members of bibra.

News Home Guest Write For Us? Contact Us